Outcome measurea | Dexamethasone | Placebo | P value |
---|---|---|---|
Glucose AUC15 in mmol/L × hour | 126.5 (13.0) | 114.4 (13.9) | <0.001 |
Glucose level in mmol/L at postoperative ICU admission | 8.7 (2.3) | 6.9 (2.0) | <0.001 |
Hyperglycemic index in mmol/Lb (cutoff >6.0Â mmol/L) | 1.97 (0.85) | 1.28 (0.81) | <0.001 |
Hyperglycemic index in mmol/Lc (cutoff >8.0Â mmol/L) | 0.74 (0.69) | 0.35 (0.51) | <0.001 |
Hypoglycemia incidence, N (%)d | 3 (1.2) | 20 (8.0) | <0.001 |
Lactate AUC15 in mmol/L × hour | 25.8 (13.1) | 19.9 (11.2) | <0.001 |
Lactate level in mmol/L at postoperative ICU admission | 2.1 (1.0) | 1.6 (0.7) | <0.001 |
Insulin consumption in IU at first 15Â hours of ICU admission | 32.0 (19.9) | 16.3 (14.5) | <0.001 |
ICU length of stay in hours, median (IQR) | 21.9 (19.3-23.7) | 22.7 (20.6-45.0) | 0.001 |
ICU length of stay ≥24 hours, N (%) | 62 (25.0) | 98 (39.2) | 0.001 |
ICU readmissions, N (%) | 13 (5.2) | 10 (4.0) | 0.51 |
Hospital length of stay in days, median (IQR) | 10 (8-16) | 11 (8-16) | 0.53 |
Postoperative inotropic or vasopressor requirement, N (%) | 125 (50.6) | 144 (57.6) | 0.14 |
Postoperative surgical site infections, N (%) | 5 (2.0) | 6 (2.4) | 0.77 |
Postoperative gastrointestinal hemorrhage, N (%) | 3 (1.2) | 1 (0.4) | 0.37 |
30-day mortality, N (%)e | 4 (1.6) | 6 (2.4) | 0.76 |